0001209191-21-050440.txt : 20210809 0001209191-21-050440.hdr.sgml : 20210809 20210809173403 ACCESSION NUMBER: 0001209191-21-050440 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210809 FILED AS OF DATE: 20210809 DATE AS OF CHANGE: 20210809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Delfini Lisa CENTRAL INDEX KEY: 0001873253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38886 FILM NUMBER: 211157660 MAIL ADDRESS: STREET 1: C/O TREVI THERAPEUTICS, INC. STREET 2: 195 CHURCH STREET, FL. 14 CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trevi Therapeutics, Inc. CENTRAL INDEX KEY: 0001563880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450834299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-304-2499 MAIL ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-09 0 0001563880 Trevi Therapeutics, Inc. TRVI 0001873253 Delfini Lisa C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, 14TH FLOOR NEW HAVEN CT 06510 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 1.97 2021-08-09 4 A 0 100000 0.00 A 2031-08-08 Common Stock 100000 100000 D This option was granted on August 9, 2021. The 100,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on August 9, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter, through August 9, 2025. /s/ Christopher Galletta, attorney-in-fact 2021-08-09